Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Vedani

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
ALTEX|January 1, 1991
[Computer-Aided Drug Design: An Alternative to Animal Testing in the Pharmacological Screening]Angelo Vedani
ALTEX|January 1, 1994
[Pseudoreceptor modeling - a tool in the pharmacological screening process]Angelo Vedani
ALTEX|January 1, 1997
[Target proteins and mechanisms of ochratoxin toxicity. A contribution to the identification of potential ochratoxin antagonists]Angelo Vedani, Peter Zbinden
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2016
VirtualToxLab: Exploring the Toxic Potential of Rejuvenating Substances Found in Traditional MedicinesMartin Smieško, Angelo Vedani
Alternatives to Laboratory Animals : ATLA|December 19, 2009
In silico toxicology in drug discovery - concepts based on three-dimensional modelsAngelo Vedani, Martin Smiesko
ALTEX|January 1, 1996
[Orchratoxin A and B: A three-dimensional molecular model for a mechanistic explanation of their toxicity]Angelo Vedani, Bruinink Arend
Journal of Medicinal Chemistry|May 17, 2002
5D-QSAR: the key for simulating induced fit?Angelo Vedani, Max Dobler
Journal of Chemical Information and Modeling|September 26, 2006
Combining 4D pharmacophore generation and multidimensional QSAR: modeling ligand binding to the bradykinin B2 receptorMarkus A Lill, Angelo Vedani
ALTEX|February 15, 2001
[Ochratoxins: Molecular strategies for developing an antidote]Daniel R. McMasters, Angelo Vedani
Toxicology and Applied Pharmacology|April 24, 2012
VirtualToxLab - a platform for estimating the toxic potential of drugs, chemicals and natural productsAngelo Vedani, Max Dobler, Martin Smieško
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
ALTEX|January 1, 1991
[Computer-Aided Drug Design: An Alternative to Animal Testing in the Pharmacological Screening]Angelo Vedani
ALTEX|January 1, 1994
[Pseudoreceptor modeling - a tool in the pharmacological screening process]Angelo Vedani
ALTEX|January 1, 1997
[Target proteins and mechanisms of ochratoxin toxicity. A contribution to the identification of potential ochratoxin antagonists]Angelo Vedani, Peter Zbinden
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2016
VirtualToxLab: Exploring the Toxic Potential of Rejuvenating Substances Found in Traditional MedicinesMartin Smieško, Angelo Vedani
Alternatives to Laboratory Animals : ATLA|December 19, 2009
In silico toxicology in drug discovery - concepts based on three-dimensional modelsAngelo Vedani, Martin Smiesko
ALTEX|January 1, 1996
[Orchratoxin A and B: A three-dimensional molecular model for a mechanistic explanation of their toxicity]Angelo Vedani, Bruinink Arend
Journal of Medicinal Chemistry|May 17, 2002
5D-QSAR: the key for simulating induced fit?Angelo Vedani, Max Dobler
Journal of Chemical Information and Modeling|September 26, 2006
Combining 4D pharmacophore generation and multidimensional QSAR: modeling ligand binding to the bradykinin B2 receptorMarkus A Lill, Angelo Vedani
ALTEX|February 15, 2001
[Ochratoxins: Molecular strategies for developing an antidote]Daniel R. McMasters, Angelo Vedani
Toxicology and Applied Pharmacology|April 24, 2012
VirtualToxLab - a platform for estimating the toxic potential of drugs, chemicals and natural productsAngelo Vedani, Max Dobler, Martin Smieško
Pageof 5